Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

This page is alzhub.org's plain-English summary of a published study, not the paper itself. It is generated from the record we hold for this study, sourced and linked below — check the original for the full text and methods.

✓ Peer-reviewed alzhub usefulness score 37 out of 100. Risk factors

Topic: Risk, prevention and care in population studies

Plain-language summary

All the five dimensional SDOH disadvantages were significantly associated with higher odds of both dementia and MCI in the overall sample (p <0.05) (Figure 1). Non-Hispanic Black participants had a stronger association between dimensional SDOH disadvantages and dementia. Four out of the five associations (economic disadvantage, educational disadvantage, neighborhood disadvantage, social disadvantage) with MCI were stronger among non-Hispanic White participants. Dose response associations were observed between the number of dimensional SDOH disadvantages and dementia, as well as the number of SDOH dimensional disadvantages and MCI. A broad range of SDOH were associated with cognitive impairment, with the strength of these associations varying across different racial/ethnic groups. This suggests the need for tailored strategies to address SDOH issues in racial/ethnic groups.

What this study adds

Evidence grade: Low

The record lists 3,229 participants. This study found that five types of social disadvantage were linked to higher odds of both dementia and mild cognitive impairment, with the strength of these links differing across racial and ethnic groups. It does not test any treatment, cure or prevention, but suggests that strategies addressing social determinants may need to be tailored to different groups.

Taken from this record’s own fields, not from reading the paper. The grade is assigned from the abstract’s wording; what that means.

Cite this study APA, Vancouver, BibTeX · download .bib or .ris

APA 7th

Wang, S., Nguyen, U., Zhou, Z., O’Bryant, S. E., Yaffe, K. S., Johnson, L. A., et al. (2025). Associations of social determinants of health (SDOH) with dementia and mild cognitive impairment (MCI), the HABS‐HD Study. Alzheimer s & Dementia. https://doi.org/10.1002/alz70860_096396

Vancouver

Wang S, Nguyen U, Zhou Z, O’Bryant SE, Yaffe KS, Johnson LA, et al. Associations of social determinants of health (SDOH) with dementia and mild cognitive impairment (MCI), the HABS‐HD Study. Alzheimer s & Dementia. 2025. doi:10.1002/alz70860_096396. PMID: 41434953.

BibTeX

@article{wang2025-41434953,
  author  = {Wang, Shanshan and Nguyen, Uyen‐sa and Zhou, Zhengyang and O’Bryant, Sid E. and Yaffe, Kristine S. and Johnson, Leigh A and Nandy, Rajesh Ranjan},
  title   = {{Associations of social determinants of health (SDOH) with dementia and mild cognitive impairment (MCI), the HABS‐HD Study}},
  journal = {Alzheimer s \& Dementia},
  year    = {2025},
  doi     = {10.1002/alz70860_096396},
  pmid    = {41434953},
  url     = {https://doi.org/10.1002/alz70860_096396}
}

Built from the record alzhub holds for this paper, not looked up. Volume, issue and page numbers are not held in the record. The record names 7 authors; APA and Vancouver show the first six, BibTeX and the downloads carry all of them. Check the citation against the original before you use it.

Key findings

Why it matters

This study found that five types of social disadvantage were linked to higher odds of both dementia and mild cognitive impairment, with the strength of these links differing across racial and ethnic groups. It does not test any treatment, cure or prevention, but suggests that strategies addressing social determinants may need to be tailored to different groups.

Study details

How this study scored 37/100
How this study's score is builtJournal tier 7 of 10; Journal's citation record 2 of 4; Study design 0 of 12; Strength of evidence 1 of 5; Peer-review validation 10 of 10; How recent 4 of 5; Sample size 3 of 4; Effect reported 0 of 3; Studied in people 3 of 3; Randomized / blinded 0 of 2; Times cited 0 of 7; Citations per year 0 of 5; Impact for its field and year 0 of 6; Cited by studies here 0 of 6; Still being cited 0 of 4; Senior author's track record 0 of 4; Institution's track record 2 of 3; Multicenter collaboration 1 of 3; Indexed in PubMed 2 of 2; Free to read 2 of 2. Total 37 of 100.37 of 100 points earned63 not earned

Published in a peer-reviewed journal. Scored zero for study design, effect reported and randomized / blinded because the record does not state it.

ComponentPointsWhy
Journal tier 7 / 10 Tier 3 — peer-reviewed journal (Alzheimer s & Dementia)
Journal's citation record 2 / 4 Alzheimer s & Dementia: journal h-index 228 (OpenAlex, 2026-10-29)
Study design 0 / 12 No study design recorded — scores zero, not guessed (not stated in the record — scored 0)
Strength of evidence 1 / 5 Rated “low” in our summary
Peer-review validation 10 / 10 Peer-reviewed. Published as an article in a named peer-reviewed journal.
How recent 4 / 5 2025 — within 3 year(s) of the newest study here
Sample size 3 / 4 3,229 participants
Effect reported 0 / 3 No effect size reported — scores zero (not stated in the record — scored 0)
Studied in people 3 / 3 Studied in people (participant count stated)
Randomized / blinded 0 / 2 No randomization or blinding stated — scores zero (not stated in the record — scored 0)
Times cited 0 / 7 Cited 0 times (OpenAlex, 2026-10-10)
Citations per year 0 / 5 0.0 citations a year over 3 year(s) since 2025
Impact for its field and year 0 / 6 Cited 0.0× the average for papers of its field and year (OpenAlex FWCI)
Cited by studies here 0 / 6 No other study in this library cites it
Still being cited 0 / 4 Cited 0 times in 2024–2026 (2026 still in progress; OpenAlex)
Senior author's track record 0 / 4 Last-listed author The Health and Aging Brain Study (HABS‐HD) Study Team: h-index 1 (OpenAlex, whole career)
Institution's track record 2 / 3 University of California, San Francisco: institution h-index 1,915 (OpenAlex)
Multicenter collaboration 1 / 3 OpenAlex lists 3 institution(s) in 1 country
Indexed in PubMed 2 / 2 Indexed in PubMed (PMID 41434953)
Free to read 2 / 2 Free to read
Total 37 / 100 —

What each of these 20 components measures, and what this score is not →

Read the original

Full text: free to read — OpenAlex lists this copy as free to read: the link above (checked 6 Feb 1020).

Studies in the library that share something with this one. The line above each title says what.

Related studies in Risk factors from nearby years

Also tagged “biobank”

1,084 studies in the library carry the topic tag “biobank”; these are this study's neighbours in a fixed, alphabetical-by-hash tour of them, not the closest in content. All 1,084 tagged studies.

Studies sharing this one's topic tags

Similar studies

More on Risk factors

See all studies in Risk factors →